GERN
Geron Corp
Price:  
1.32 
USD
Volume:  
4,168,711.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

GERN Relative Valuation

-192.7%
Upside

As of 2025-09-18, the Relative Valuation of Geron Corp (GERN) is (1.22) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.32 USD, the upside of Geron Corp based on Relative Valuation is -192.7%.

The range of the Relative Valuation is (0.95) - (1.62) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 4.5x - 11.8x 8.2x
Forward P/E multiples 6.9x - 12.3x 9.6x
Fair Price (0.95) - (1.62) (1.22)
Upside -172.1% - -223.1% -192.7%
1.32 USD
Stock Price
(1.22) USD
Fair Price

GERN Relative Valuation - Historical P/E Data

Date P/E
2025-09-17 -9.21
2025-09-16 -9.06
2025-09-15 -9.21
2025-09-12 -9.21
2025-09-11 -9.57
2025-09-10 -9.35
2025-09-09 -9.86
2025-09-08 -9.93
2025-09-05 -10.15
2025-09-04 -10.00
2025-09-03 -10.15
2025-09-02 -10.66
2025-08-29 -10.15
2025-08-28 -10.37
2025-08-27 -10.22
2025-08-26 -10.58
2025-08-25 -10.29
2025-08-22 -10.58
2025-08-21 -10.37
2025-08-20 -10.08
2025-08-19 -10.37
2025-08-18 -10.44
2025-08-15 -10.51
2025-08-14 -10.51
2025-08-13 -10.37
2025-08-12 -9.79
2025-08-11 -9.86
2025-08-08 -9.28
2025-08-07 -9.42
2025-08-06 -10.08
2025-08-05 -8.70
2025-08-04 -8.77
2025-08-01 -8.48
2025-07-31 -8.34
2025-07-30 -7.97
2025-07-29 -8.23
2025-07-28 -8.34
2025-07-25 -9.13
2025-07-24 -9.28
2025-07-23 -9.64
2025-07-22 -9.28
2025-07-21 -8.92
2025-07-18 -8.99
2025-07-17 -9.35
2025-07-16 -9.21
2025-07-15 -9.13
2025-07-14 -9.71
2025-07-11 -9.57
2025-07-10 -10.00
2025-07-09 -10.44